The updated 8k on 31 Dec 2012 is something to cheer about--setting operations in China should mean access to an enormous market for many years to come and positively impact revenues and stock price. Real opportunity at this price for big gains. here is copy of 8k
Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Item 1.01 Entry into a Material Definitive Agreement.
On December 28, 2012, Dais Analytic Corporation (the "Company") amended its Securities Purchase Agreement, dated October 17, 2012 (the "Securities Purchase Agreement"), with Green Valley International Investment Management Company Limited (the "Investor") pursuant to which the Investor will purchase up to $7.0 million of the Company's common stock, $0.01 par value per share (the "Common Stock"), and warrants (the "Warrants") to purchase up to 17,500,000 shares of Common Stock.
Pursuant to the terms of the Securities Purchase Agreement, the Investor has purchased $1,750,000 of Common Stock and Warrants. The amendment, requires the Purchaser to purchase the remaining Common Stock and Warrants on or before January 25, 2013. This extension will allow the Company and the Investor to create and capitalize a wholly owned subsidiary to be organized and located in China (the "Dais China Subsidiary"). Pursuant to the amendment, the Company shall use $4.0 million of the aggregate proceeds from the sale of Common Stock and Warrants for capital expenditures, working capital, and general business purposes. The Company shall use the remaining proceeds from the sale of the Common Stock and Warrants to create and capitalize the Dais China Subsidiary.
The Amendment to Securities Purchase Agreement is filed as Exhibit 10.1 to this Current Report on Form 8-K. The foregoing summary of the terms of the Amendment to Securities Purchase Agreement are subject to, and qualified in their entirety by, such document attached hereto, which is incorporated herein by reference.
Sentiment: Strong Buy
don't see that--they sold warrents to raise money to pay off all debt. That's a good sign. Products good, debt nil, have some money to market--I expect rise in price all signs pointing up
Sentiment: Strong Buy
finished? not likely unless you mean its finished being a 11 cent stock. it's got great products, just got $7 million in finances and now a great balance sheet. Stock is real opportunity at this level. I bought over 100k shares and expect stock to be several dollars in time as it has the right products at the right time. Global demand for its break through products will only surge as environmental problems mount.
Sentiment: Strong Buy
I look at it differently, shares weren't dumped, new buyers were coming in so good news must be coming. Average volume a month ago was 20k now its double at 39k. The glass is half full not empty.
good point! like most longs i'm hoping for better things and was disapointed that stock didnt move much on news of succesful trials
Is there any news on trials? It seems what this stock is needing and waiting for is results of trials. When will these be completed and reported? Anyone know? thank you
yes I'm bullish LT. I think someone will buy them for the patents. I used to work for Pharm firm but I'm not a scientist. Nevertheless, my experience is these type of firms rarely go it alone LT but get bought out along the way and that is what I'm banking on with TNGN.
Also post pharm experience I worked in venture capital and we invested early stage in a Bio firm with not half the bells and whistles of TNGN but we sold it to Genetech for 20x cash on cash basis.
I believe after the trials we will see some movement as that is what the big pharm is waiting on.
I warned you only an idiot would shot a 50 cent stock. I'll give you another piece of advice cover your short while price is 55 cents as this stock is on the way up and it will only get more painful for you.
had GM not been bailed out and with Fukashima earthquake Ford would be at $100 and breaking all sales records and employing all the laid off GM employees. Government intervention does not create or save jobs it only artificially chooses sides, the side that greased their palms.
obviously if company were well run stock wouldn't have dropped so much. Yet, I suspect prior to IPO management ran company by PR releases and now they are focused on real science, the clinical trials. This in ST had dropped the price but if trials go positively they'll be a nice pop up and many shorts will lose quite a bit. nothing against shorts, this is a speculative investment for me--if it goes to zero I lose a little but upside for this breakthrough technology could be huge. On the other hand I do not see the point in shorting a stock like TNGN--at most one can gain 50 cents a share but it is very unlikely that stock could go to zero. But a short could lose their shirt on sudden jumps. Nothing wrong with shorting, perse, but when I short I do it on large cap fairly predictable stocks.
no ones dumping. If the volume indicated dumping--stock would have gone down that day but on the 7x volume day--stock went up meaning demand greater than supply. Nice try but you need to go back to economics 101 on supply and demand ratio on pricing.
Why would anyone short a stock at 50 cents? AT most stock could go down 50 cents yet over night you could get burned without notice as 4 things are going against you.
1. It's an election year- manipulation will be to push stocks up.
2. Breaking news on the clinical study
3. Strategic partner purchase tngn
4. CFO already hinted at reverse split to get stock over a dollar.
Lets do the math. Let's say you have $100,000 to invest which given you're shorting a stock at 50 cents I dont' think any of you have the brains to save $100k.
AT 50 cents you short the stock so you just borrowed 200,000 shares to sell. If stock goes down 10 cents you earn $20,000.
But what if a clinical announcement is made and stock shoots up to $1.50? Now you need to replace 200,000 shares you borrowed by paying $1.50. This will cost you $300,000 so you're original $100,000 is now worth negative $200,000.
Your risk reward ratio is really bad. You can at most gain tens of thousands but you can lose hundreds of thousands, even millions.
The shorting the stock strategy should be played on big stocks with high volumes--you're going to lose your shirt on Tngn.
A wise man once told me that when you get in an argument with a fool, people walking by can't tell who is the fool. I just popped on the board and in reading your post I can't tell who the fool is--the original poster or you?
Whether you like Obama or not one thing is clear--for the economy to recover he needs to go. When a football team is losing--sometimes the best way to turn the tables is to replace the coach. A new coach brings not only a new way of doing things but suspends peoples expectations of losing and often creates confidence and faith that the team can win and will win.
It may not be the coaches fault-the players may in fact suck but replacing the coach or leader often does the trick.
I remember when Apple shares were $25 under Skully. I'm sure he did his best and he was no dummy but consumers, investors all lost faith in him at the helm and a change of leadership brought Apple to eventually lead the tech sector and trade at $500 plus.
i also remember under Carter--we had the misery index of 20% inflation, 20% unemployment and hostages in Iran. Jimmy Carter was a decent man, I voted for him but I have to admit when Reagan came into office he restored a faith in America and he curbed inflation and reduced unemployment to around 8%.
Wheter one is an Obama fan or not--it doesnt' matter--the country needs a new coach as people have given up on the team and the leader.
I look on it as a positive. It's cash asset alone (not including patents) is worth about $2.36 a share.
It has money to last until May 2012. It has clinical trials ongoing. It is speaking with potential investors. One of these days it's going to explode to the upside IMHO.
Essentially J ^ & J and any large firm could pay 54 cents to receive $2.3 6 in cash and all its patents.
just saw someone bought 30,000 shares at open. I would suspect it is an institutional fund and hopefully more will follow and even more hopefully--perhaps they know something positive that we haven't learned of yet
From the proxy statement I now understand Tengion's LT strategy. For some time I was worried of TNGN delisting since it has fallen below $1 but now I am not worried one bit. Why? The company has plenty of cash to fund its research and trials through May 2012. It's strategy is to put the foundation of this company on the outcome of the research trials, not PR not fluff but research outcomes. And in the meantime it is courting big pharma suitors for sale. Big pharma is waiting on the outcome of trials before it jumps in and personally I'm confident that the outcome of trials will be good.
So even if TNGN delists--I dont' care--my shares will be bought by Big pharma for a multiple above the 80 cents the company is trading now so personally I'm considering adding another 10,000 shares to my position as my success or failure of my investment is linked to the trials not TNGN's listing on NAsdaq
Did anyone else read proxy statement that Tengion has enough money to fund itself through May 2012. This is more than enough time to get possitive results from research trials and find a suitor so the future for this stock looks good.